Screener
HealthEquity HQY Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands) | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Repurchases of common stock | (123,314) | (59,065) |
| Principal payments on long-term debt | (15,000) | — |
| Settlement of client-held funds obligation, net | 716 | 1,451 |
| Proceeds from exercise of common stock options | 418 | 965 |
| Net cash used in financing activities | (137,180) | (56,649) |
| Decrease in cash and cash equivalents | (53,558) | (8,054) |
| Beginning cash and cash equivalents | 318,927 | 295,948 |
| Ending cash and cash equivalents | $265,369 | $287,894 |
Item 1. Financial statements
FAQ
- What is HealthEquity's financing cash flow?
- HealthEquity (HQY) reported financing cash flow of -$137.18M in Q1 2026.
- How has HealthEquity's financing cash flow changed year-over-year?
- HealthEquity's financing cash flow decreased by 142.2% year-over-year, from -$56.65M to -$137.18M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about HealthEquity's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude